Literature DB >> 32333104

A child confirmed COVID-19 with only symptoms of conjunctivitis and eyelid dermatitis.

Ping Wu1, Liang Liang2, ChunBao Chen3, ShengQiong Nie1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32333104      PMCID: PMC7181963          DOI: 10.1007/s00417-020-04708-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.535


× No keyword cloud information.
Dear Editor, As we all know, the 2019 novel coronavirus disease (COVID-19) infected by SARS-CoV-2 are spreading worldwide. It was reported that there were different clinical features between pediatric and adult patients with COVID-19 [1]. Our previous study had shown that conjunctivitis symptoms were found in a minority of adult patients confirmed COVID-19, with positive results of viral nucleic acid in conjunctival swab samples [2]. Nevertheless, there are no reports in the medical literature at this time, to our knowledge, on children infected by SARS-CoV-2 with ocular abnormalities. Here we firstly report an infected boy characterized by conjunctivitis and eyelid dermatitis without any other symptom. The child, 2 years and 10 months old, was detected and confirmed through community screening with positive result of SARS-Cov-2 nucleic acid in his nasopharyngeal swabs on February 17, 2020. He likely acquired SARS-CoV-2 infection from his household member because of his father and grandma diagnosed before. He was quarantined at a government designated hotel with his mother, for being asymptomatic initially. On day 7 of confinement, the child presented with conjunctivitis and eyelid dermatitis (Fig. 1), and was referred to our hospital subsequently. Admission tests reconfirmed the SARS-CoV-2 infection by RT-PCR, meanwhile revealed myocardial damage and atypical change in lymphocyte count (Table 1), with normal chest CT. After treatment depending on the national protocol in China [3], conjunctivitis and eyelid dermatitis gradually disappeared 5 days later. From days 10 to 12 of admission, negative results of viral nucleic acid twice in 48 h, with positive IgG but negative IgM of the virus in serum, indicated that the virus had been cleared [4]. The child left hospital on March 7, 2020, with no respiratory and other systemic symptoms until now.
Fig. 1

a and b Day 1 of admission. The pictures showed conjunctival congestion and eyelid redness and swelling in the left eye

Table 1

Partial results of blood tests after admission

1st day11th dayReference range
White blood cell count, *109/L9.575.023.5–9.5
Lymphocyte count,*109/L4.483.201.1–3.2
Neutrophil count,*109/L4.291.221.8–6.3
Platelet count,*109/L289298125–350
Procalcitonin (PCT), ng/mL< 0.050–0.05
C- reactive protein (CRP), mg/L6.50.50–10
Troponin I (CTnI), μg/L< 0.01< 0.010–0.01
Myoglobin (MYO), μg/L176010–46
Creatine kinase (CK), IU/L29550–310
Creatine kinase isoenzyme–MB (CKMB), μg/L6.386.770–5.1
Lactate dehydrogenase (LDH), IU/L329120–250
Alanine aminotransferase (ALT), U/L24209–50
Aspartate minotransferase (AST), U/L353015–40
Urea, mmol/L5.373.1–8.0
Creatinine, umol/L27.157–97

“–” represents no retests in this admission

a and b Day 1 of admission. The pictures showed conjunctival congestion and eyelid redness and swelling in the left eye Partial results of blood tests after admission “–” represents no retests in this admission Our child was found muscle enzyme elevation unintentionally; meanwhile, the trend of recovery was not clear when leaving hospital (Table 1). It indicated that we should closely track the blood indexes of child patients as soon as earlier to know the condition of myocardium and whole system after diagnosed even though without any clinical manifestation. Lymphocyte count usually decreased in the early stage of most adult cases [5], while that of this child was slightly higher than normal in admission tests. To some extent, it was related to that the count and proportion of lymphocytes in children under 5 years old are higher than those in adults in the general population. Therefore, the significance of this test for early diagnosis of COVID-19 should be combined with age and need to be confirmed by large sample data. Studies had shown that ACE2 is a receptor of SARS-CoV-2 to invasion [6]. ACE2 is expressed not only in human type II alveolar epithelial cells, but also in cornea and conjunctiva [7], suggesting that ocular surface tissue may also be a potential target tissue infected by SARS-CoV-2. Our previous report had shown that conjunctivitis symptoms were found in a small number of adult patients confirmed COVID-19 [2]. However, so far, there has been no report on infected children with eye symptoms. This case showed a child involved conjunctivitis and eyelid dermatitis on day 7 of COVID-19 confirmed. It may be caused by virus infection, or by secondary bacterial infection with poor body resistance after systemic virus infection. Therefore, we suggest that doctors should not forget to conduct COVID-19 screening when children come to hospital for ocular abnormalities during this epidemic period. Except for the specific detection of viral nucleic acid, the results of other laboratory tests of SARS-COV-2 infection in children had no obvious specificity.
  6 in total

1.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

2.  Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis.

Authors:  Zhengtu Li; Yongxiang Yi; Xiaomei Luo; Nian Xiong; Yang Liu; Shaoqiang Li; Ruilin Sun; Yanqun Wang; Bicheng Hu; Wei Chen; Yongchen Zhang; Jing Wang; Baofu Huang; Ye Lin; Jiasheng Yang; Wensheng Cai; Xuefeng Wang; Jing Cheng; Zhiqiang Chen; Kangjun Sun; Weimin Pan; Zhifei Zhan; Liyan Chen; Feng Ye
Journal:  J Med Virol       Date:  2020-04-13       Impact factor: 2.327

3.  Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.

Authors:  Yushun Wan; Jian Shang; Rachel Graham; Ralph S Baric; Fang Li
Journal:  J Virol       Date:  2020-03-17       Impact factor: 5.103

4.  Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China.

Authors:  Ping Wu; Fang Duan; Chunhua Luo; Qiang Liu; Xingguang Qu; Liang Liang; Kaili Wu
Journal:  JAMA Ophthalmol       Date:  2020-05-01       Impact factor: 7.389

Review 5.  Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement.

Authors:  Kunling Shen; Yonghong Yang; Tianyou Wang; Dongchi Zhao; Yi Jiang; Runming Jin; Yuejie Zheng; Baoping Xu; Zhengde Xie; Likai Lin; Yunxiao Shang; Xiaoxia Lu; Sainan Shu; Yan Bai; Jikui Deng; Min Lu; Leping Ye; Xuefeng Wang; Yongyan Wang; Liwei Gao
Journal:  World J Pediatr       Date:  2020-02-07       Impact factor: 9.186

6.  Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection.

Authors:  Xin Zou; Ke Chen; Jiawei Zou; Peiyi Han; Jie Hao; Zeguang Han
Journal:  Front Med       Date:  2020-03-12       Impact factor: 4.592

  6 in total
  31 in total

1.  [Clinical features of coronavirus disease 2019 in children: a systemic review of severe acute respiratory syndrome, Middle East respiratory syndrome, and coronavirus disease 2019].

Authors:  Yang He; Jun Tang; Meng Zhang; Hao-Ran Wang; Wen-Xing Li; Tao Xiong; You-Ping Li; De-Zhi Mu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-08

2.  A systematic review of the histopathologic survey on skin biopsies in patients with Corona Virus Disease 2019 (COVID-19) who developed virus or drug-related mucocutaneous manifestations.

Authors:  Niloufar Najar Nobari; Farnoosh Seirafianpour; Milad Dodangeh; Afsaneh Sadeghzadeh-Bazargan; Elham Behrangi; Samaneh Mozafarpoor; Azadeh Goodarzi
Journal:  Exp Dermatol       Date:  2021-05-24       Impact factor: 4.511

Review 3.  Diagnostic performance of chest computed tomography for COVID-19 in children: a systematic review and meta-analysis of clinical and computed tomography features in 987 patients.

Authors:  Mahitab Ghoneim; Riham Eid; Nashwa Hamdy; Doaa Shokry; Mohammed A Salem; Ahmed El-Morsy; Ali H Elmokadem
Journal:  Pol J Radiol       Date:  2022-03-02

4.  COVID-19 and the Eye.

Authors:  Yueyang Zhong; Kai Wang; Yanan Zhu; Danni Lyu; Ke Yao
Journal:  J Infect       Date:  2020-05-28       Impact factor: 6.072

Review 5.  A comprehensive review on clinical and mechanistic pathophysiological aspects of COVID-19 Malady: How far have we come?

Authors:  Baila Shakaib; Tanzeel Zohra; Aamer Ikram; Muhammad Bin Shakaib; Amna Ali; Adnan Bashir; Muhammad Salman; Mumtaz Ali Khan; Jamil Ansari
Journal:  Virol J       Date:  2021-06-07       Impact factor: 4.099

Review 6.  Innate Immunity in Children and the Role of ACE2 Expression in SARS-CoV-2 Infection.

Authors:  Mario Dioguardi; Angela Pia Cazzolla; Claudia Arena; Diego Sovereto; Giorgia Apollonia Caloro; Antonio Dioguardi; Vito Crincoli; Luigi Laino; Giuseppe Troiano; Lorenzo Lo Muzio
Journal:  Pediatr Rep       Date:  2021-07-02

Review 7.  Patients with specific skin disorders who are affected by COVID-19: What do experiences say about management strategies? A systematic review.

Authors:  Niloufar Najar Nobari; Azadeh Goodarzi
Journal:  Dermatol Ther       Date:  2020-07-07       Impact factor: 3.858

8.  A Case of COVID-19 with Late-Onset Rash and Transient Loss of Taste and Smell in a 15-Year-Old Boy.

Authors:  Antonino Maniaci; Giannicola Iannella; Claudio Vicini; Piero Pavone; Giuseppe Nunnari; Raffaele Falsaperla; Paola Di Mauro; Salvatore Ferlito; Salvatore Cocuzza
Journal:  Am J Case Rep       Date:  2020-08-20

9.  Clinical and Prodromal Ocular Symptoms in Coronavirus Disease: A Systematic Review and Meta-Analysis.

Authors:  Takenori Inomata; Koji Kitazawa; Toshiki Kuno; Jaemyoung Sung; Masahiro Nakamura; Masao Iwagami; Hisato Takagi; Akie Midorikawa-Inomata; Jun Zhu; Keiichi Fujimoto; Yuichi Okumura; Maria Miura; Kenta Fujio; Kunihiko Hirosawa; Yasutsugu Akasaki; Mizu Kuwahara; Reza Dana; Akira Murakami
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

10.  Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review.

Authors:  Farnoosh Seirafianpour; Sogand Sodagar; Arash Pour Mohammad; Parsa Panahi; Samaneh Mozafarpoor; Simin Almasi; Azadeh Goodarzi
Journal:  Dermatol Ther       Date:  2020-08-06       Impact factor: 3.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.